Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis...

Area of Science:

• Infectious Diseases
• Pulmonology
• Neurology

Background:

• The COVID-19 pandemic has resulted in a significant number of survivors experiencing Post-COVID-19 Syndrome (PC19S).
• Current PC19S diagnosis relies heavily on subjective patient history and symptomatology, lacking objective measures.
• This diagnostic approach presents challenges in patient management, resource allocation, and monitoring clinical progression.

Purpose of the Study:

• To review current evidence for diagnosing Post-COVID-19 Syndrome using a triple assessment approach.
• To explore the development of objective assessment tools for PC19S.
• To evaluate existing rehabilitation programs and identify research gaps.

Main Methods:

• Narrative review of existing literature on Post-COVID-19 Syndrome diagnosis.
• Analysis of diagnostic criteria including clinical symptomatology, biochemical markers, and imaging evidence.
• Evaluation of current rehabilitation strategies and clinical trials for PC19S patients.

Main Results:

• The current diagnostic methods for PC19S are subjective and prone to reporting errors.
• A triple assessment (clinical, biochemical, imaging) offers a potential pathway towards more objective diagnosis.
• Existing rehabilitation efforts primarily focus on cardiorespiratory and psychiatric aspects, with a need for broader approaches.

Conclusions:

• Objective diagnostic tools are crucial for effective Post-COVID-19 Syndrome management and resource allocation.
• A comprehensive triple assessment strategy can improve patient monitoring, prognosis, and rehabilitation planning.
• Further research is essential to develop and validate objective assessment tools for PC19S.